{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "exchangeTimezoneName": "Asia/Seoul", "exchangeTimezoneShortName": "KST", "currency": "KRW", "market": "kr_market", "esgPopulated": false, "gmtOffSetMilliseconds": 32400000, "exchange": "KOE", "longName": "Medifron DBT Co., Ltd.", "shortName": "Medifron DBT", "regularMarketPrice": 1580.0, "regularMarketChangePercent": 2.5974026, "marketState": "PREPRE", "fiftyTwoWeekHighChangePercent": -0.33333334, "fiftyTwoWeekLow": 1035.0, "fiftyTwoWeekHigh": 2370.0, "fiftyTwoWeekLowChange": 545.0, "fiftyTwoWeekLowChangePercent": 0.52657, "fiftyTwoWeekRange": "1035.0 - 2370.0", "fiftyTwoWeekHighChange": -790.0, "sharesOutstanding": 29439100, "fiftyDayAverage": 1444.24, "fiftyDayAverageChange": 135.76001, "fiftyDayAverageChangePercent": 0.094001, "twoHundredDayAverage": 1477.32, "twoHundredDayAverageChange": 102.68005, "twoHundredDayAverageChangePercent": 0.069504276, "marketCap": 46513778688, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1043107200000, "priceHint": 2, "regularMarketChange": 40.0, "regularMarketTime": 1683873018, "regularMarketDayHigh": 1641.0, "regularMarketDayRange": "1501.0 - 1641.0", "regularMarketDayLow": 1501.0, "regularMarketVolume": 2232632, "regularMarketPreviousClose": 1540.0, "bid": 1579.0, "ask": 1580.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "KOSDAQ", "financialCurrency": "KRW", "regularMarketOpen": 1540.0, "averageDailyVolume3Month": 797576, "averageDailyVolume10Day": 2753562, "symbol": "065650.KQ"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "186, Gasan digital 1-ro", "address2": "Geumcheon-gu", "city": "Seoul", "zip": "08502", "country": "South Korea", "phone": "82 2 545 9277", "fax": "82 2 545 9288", "website": "https://www.medifron.com", "industry": "", "sector": "", "longBusinessSummary": "Medifron DBT Co., Ltd., a clinical stage biopharmaceutical company, focuses on the development of Alzheimer's disease (AD) and neuropathic pain treatments, and AD diagnostics. The company was formerly known as Legend Technologies Inc. and changed its name to Medifron DBT Co., Ltd. in 2006. Medifron DBT Co., Ltd. was incorporated in 1997 and is based in Seoul, South Korea.", "fullTimeEmployees": 33, "companyOfficers": [{"maxAge": 1, "name": "Mr. Hyun-Sang  Muk", "age": 63, "title": "Chief Exec. Officer and Representative Director", "yearBorn": 1959, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Young-Ho  Kim", "age": 58, "title": "Chief Exec. Officer and Representative Director", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Dong-Bum  Im", "age": 59, "title": "Head of Information Technology Department and Director", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}